Leon Nanodrugs raises €18.5m series-A

Other participants included Signet Healthcare Partners, LifeCare Partners, CD Venture and Albany Private Equity, as well as an unnamed German family office.

The company will use the fresh capital to expand its service business and to finance collaborative development projects with pharmaceutical partners.

TVM held a final close for its TVM Life Science Ventures VII fund on $201.6m in October 2014. 

Company
Founded in 2011 in Munich, Leon Nanodrugs is a nanotechnology-based drug development company. It focuses on reformulations and reinventions of drugs on a contract or co-development basis.

People
Cornelia Beier is co-founder and managing director of Leon Nanodrugs. Hubert Birner is managing partner at TVM.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Early-stage
• Germany